- Generic name
- Methimazole
- Strength
- 10 mg
- Dosage form
- Tablet
- Manufactured by
- Renata PLC.
Metirox-10 Tablet
About Metirox-10 Tablet
Metirox-10 is a tablet containing methimazole, an anti-thyroid medicine. It is used to treat hyperthyroidism and to prepare patients for thyroid surgery or radioactive iodine therapy.
There are 5 brands of Methimazole listed in Bangladesh.
What is Metirox-10 Tablet?
Metirox-10 is a 10 mg tablet of methimazole, an anti-thyroid medicine from Renata PLC. It reduces the production of thyroid hormones and is used in Graves' disease or toxic multinodular goiter when surgery or radioactive iodine is not suitable. It is also used to ease hyperthyroid symptoms before thyroidectomy or radioactive iodine therapy. Methimazole does not inactivate thyroid hormones already stored in the body or circulating in the blood, and it does not interfere with thyroid hormones given by mouth or injection. The dose and course are decided by the doctor.
Uses of Metirox-10
Metirox-10 is used in adults with Graves' disease causing hyperthyroidism or with toxic multinodular goiter when surgery or radioactive iodine therapy is not an appropriate option. It is also used to reduce hyperthyroid symptoms in preparation for thyroidectomy or radioactive iodine therapy. It is an anti-thyroid medicine that works by reducing the synthesis of thyroid hormones. The doctor decides whether it is suitable and for how long it should be used.
How to use Metirox-10
Metirox-10 is taken by mouth. The doctor decides the dose, how often it is taken, and how long the course lasts. The total daily amount is usually divided into three doses taken at about eight-hour intervals, but this should be confirmed with your doctor or pharmacist. Do not change the dose or stop the medicine on your own. If you miss a dose, ask your doctor or pharmacist for advice. Swallow the tablet as directed.
Side effects of Metirox-10
Common side effects include skin rash, hives, nausea, vomiting, stomach discomfort, joint pain, tingling, loss of taste, hair loss, muscle pain, headache, itching, drowsiness, nerve inflammation, swelling, dizziness, skin pigmentation, jaundice, salivary gland swelling, and lymph node swelling. Rare but serious effects include low white blood cell counts, low platelets, aplastic anemia, drug fever, lupus-like syndrome, insulin autoimmune syndrome, hepatitis, and kidney inflammation. Seek medical advice if you notice unusual symptoms.
Safety and precautions
Metirox-10 is not for people with hypersensitivity to methimazole or any ingredient of the product. It can cross the placenta and may harm the fetus, especially in the first trimester, so other medicines may be preferred in pregnancy. It is excreted in breast milk; breastfeeding mothers should ask their doctor. Before starting, tell your doctor about pregnancy, breastfeeding, liver problems, blood disorders, or other medicines you take. The doctor will decide if it is safe for you and will monitor your progress.
Frequently asked questions
How should Metirox-10 be taken?
Metirox-10 is taken by mouth. The dose, frequency, and duration are decided by your doctor based on your condition. The daily amount is often divided into three doses at about eight-hour intervals, but follow your doctor's instructions exactly. Do not adjust the dose yourself.
What is Metirox-10 used for and what kind of medicine is it?
Metirox-10 is an anti-thyroid medicine containing methimazole. It is used to treat hyperthyroidism in Graves' disease or toxic multinodular goiter when surgery or radioactive iodine is not suitable, and to prepare patients for thyroid surgery or radioactive iodine therapy.
Which medicines may interact with Metirox-10?
Metirox-10 may interact with oral anticoagulants such as warfarin, beta-blockers, and digitalis glycosides. The effects of these medicines can change when thyroid function becomes normal. Tell your doctor about all medicines you take, including those without prescription, so your treatment can be adjusted safely.
Who should ask a doctor before using Metirox-10?
Pregnant or breastfeeding women, people with liver problems or blood disorders, and anyone allergic to methimazole should ask a doctor before using Metirox-10. The doctor will decide if this medicine is appropriate and will monitor for any problems during treatment.
Indications
- In patients with Graves' disease with hyperthyroidism or toxic multinodular goiter for whom surgery or radioactive iodine therapy is not an appropriate treatment option.
- To ameliorate symptoms of hyperthyroidism in preparation for thyroidectomy or radioactive iodine therapy.
Pharmacology
Dosage & Administration
Adults: The initial daily dosage is 15 mg for mild hyperthyroidism, 30 to 40 mg for moderately severe hyperthyroidism, and 60 mg for severe hyperthyroidism, divided into 3 doses at 8 hour intervals. The maintenance dosage is 5 to 15 mg daily.
Pediatric: Initially, the daily dosage is 0.4 mg/kg of body weight divided into 3 doses and given at 8 hour intervals. The maintenance dosage is approximately 1/2 of the initial dose.
Use in children & adolescents: Because of post-marketing reports of severe liver injury in pediatric patient treated with propylthiouracil, Methimazole is the preferred choice when an antithyroid drug is required for a pediatric patient.
Interaction
With food: Always take at the same moment in regard to meals, food may affect absorption unpredictably.
Contraindications
Side Effects
Rare: Agranulocytosis, granulocytopenia, thrombocytopenia and aplastic anemia, drug fever, a lupus-like syndrome, insulin autoimmune syndrome (which can result in hypoglycemic coma), hepatitis (jaundice may persist for several weeks after discontinuation of the drug), periarteritis, and hypoprothrombinemia. Nephritis occurs very rarely.
Pregnancy & Lactation
Precautions & Warnings
Agranulocytosis: Agranulocytosis is potentially a life-threatening adverse reaction of Methimazole therapy. Patients should be instructed to immediately report to their physicians if any symptoms suggestive of agranulocytosis, such as fever or sore throat occur. Leukopenia, thrombocytopenia, and aplastic anemia (pancytopenia) may also occur. The drug should be discontinued in the presence of agranulocytosis, aplastic anemia (pancytopenia), ANCA-positive vasculitis, hepatitis, or exfoliative dermatitis and the patient’s bone marrow indices should be monitored.
Liver Toxicity: Although there have been reports of hepatotoxicity associated with Methimazole, the risk of hepatotoxicity appears to be less with methimazole than with propylthiouracil, especially in the pediatric population. Drug treatment should be discontinued promptly in the event of clinically significant evidence of liver abnormality including hepatic transaminase values exceeding 3 times the upper limit of normal.
Hypothyroidism: Methimazole can cause hypothyroidism necessitating routine monitoring of TSH and free T4 levels with adjustments in dosing to maintain a euthyroid state. Because the drug readily crosses placental membranes, Methimazole can cause fetal goiter and cretinism when administered to a pregnant woman. For this reason, it is important that a sufficient, but not excessive, dose be given during pregnancy. Because Methimazole may cause hypoprothrombinemia and bleeding, prothrombin time should be monitored during therapy with the drug, especially before surgical procedures. Thyroid function tests should be monitored periodically during therapy. Once clinical evidence of hyperthyroidism has resolved, the finding of a rising serum TSH indicates that a lower maintenance dose of Methimazole should be employed.
Overdose Effects
Storage Conditions
Alternative brands of Methimazole
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.